Warning over direct-to-consumer genetic tests

GPs can expect increasing numbers of inquiries from patients wanting advice after ordering direct-to-consumer genetic tests, Australian experts say.

Overseas companies, such as 23andMe, are pushing ahead with promotion of direct-to-consumer genetic tests that claim to provide genetic risk information for 10 conditions, including Parkinson's disease and late-onset Alzheimer's disease, says public health physician adjunct Associate Professor Ken Harvey.

Writing in Australian Prescriber, Dr Harvey is urging GPs to advise their patients against purchasing these expensive, unnecessary

Latest

Trending